Wednesday, May 04, 2005 2:21:35 PM
May 04, 2005 01:09 PM US Eastern Timezone
American Dairy To Be Featured in ArcaEx Ad Campaign
BEIJING--(BUSINESS WIRE)--May 4, 2005--American Dairy, Inc. (PCX:ADIY), one of the leading producers and distributors of milk powder and soybean products in China, is pleased to announce that they were chosen by ArcaEx to kick off a new advertising campaign. This new campaign features ArcaEx's exclusive and dually listed companies, announcing that these companies are listed on ArcaEx, a facility of the Pacific Exchange.
American Dairy is the first company to list exclusively on ArcaEx since Archipelago Holdings' initial public offering on August 12, 2004. "We are proud and delighted to be among the first companies listed on ArcaEx," said Leng You-Bin, CEO of American Dairy. "Listing on ArcaEx opens us up to an entirely new investor base, one we could only have dreamed of a month ago."
Beginning in June 2005, the campaign will run in publications such as the Wall Street Journal, Barron's and Investor's Business Daily. A radio component of the campaign will run on Sirius Satellite and XM Radio.
About American Dairy
American Dairy, Inc. conducts operations in the People's Republic of China ("China") through its wholly owned subsidiary Feihe Dairy. Founded in 1962, Feihe Dairy is one of the leading producers and distributors of milk powder and soybean products in China. Feihe Dairy is located in Kedong County, China, and has been in operation since 2001. American Dairy also has a milk powder processing plant, Sanhao Dairy, in Kedong County.
Certain of the statements made herein constitute forward-looking statements that involve risks and uncertainties. In such instances, actual results could differ materially as a result of a variety of factors, including the risks associated with the effect of changing economic conditions in The People's Republic of China, variations in cash flow, reliance on collaborative retail partners, and on new product development, variations in new product and service development, risks associated with rapid technological change, and the potential of introduced or undetected flaws and defects in products and services, and other risk factors detailed in forms filed with the Securities and Exchange Commission from time to time.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM